‹ All Posts
Manjushri Sharma SEBI RA

1st Aug · SEBI-Registered Analyst

Equity PCR vs. Index PCR: Two Different Worlds

$RELINFRA Equity PCR vs. Index PCR: The Sentiment Split Not all Put/Call Ratios are created equal. Treating them as interchangeable is one of the quickest ways to misinterpret market sentiment. The truth is, the Equity PCR and Index PCR measure two entirely different populations with different motivations, and understanding this split is what separates amateur traders from professionals. Equity PCR (Baseline: ~0.60 – 0.80) is your window into the retail soul of the market. It tracks options traded on individual company stocks—think Apple, Tesla, or Reliance. This ratio is dominated by speculative retail traders and smaller institutions who are making directional bets. When the Equity PCR is low, it means everyday traders are aggressively buying calls, signaling extreme optimism and greed. When it spikes high, it reveals panic, as retail traders scramble to buy puts for protection or to bet against specific companies. Because this group is heavily influenced by emotion, news headlines, and social media hype, the Equity PCR is the most reliable gauge of "public sentiment." Index PCR (Baseline: ~1.00 – 2.00) is an entirely different beast. It tracks options on broad market benchmarks like the S&P 500 or Nifty 50. This arena is dominated by institutional giants—hedge funds, pension funds, and market makers. However, these professionals are rarely making directional bets. Instead, they use index puts as portfolio insurance. If a fund holds billions in stocks, they buy index puts to hedge against a broad market crash. Consequently, an Index PCR of 1.5 is entirely normal and does not signal fear; it simply reflects routine risk management. The Goldmine: Divergence. The most powerful signal emerges when these two ratios move in opposite directions. Imagine the Equity PCR is falling (retail traders are getting recklessly bullish) while the Index PCR is rising (institutions are quietly buying expensive crash insurance).

#StockInNews#EquityResearch#FundamentalViews#TechnicalViews#MacroViews
512 likes·46 comments